Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry)

International Journal of Cardiology

Volumn 159, Issue 3, 2012, Pages 205-210

  Okura, Narumi ^a   Ogawa, Hiroshi ^a   Katoh, Johji ^b   Yamauchi, Takao ^c   Hagiwara, Nobuhisa ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Shim Matsudo Chuo General Hospital   (Japan)

^c Sagamino Hospital   (Japan)

Author keywords

Acute myocardial infarction; Coronary risk factors; Long term prognosis; Prospective cohort study

Indexed keywords

CREATININE; FIBRINOLYTIC AGENT;

ACUTE HEART FAILURE; AGED; AGING; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; TIME FACTORS;

EID: 84865448518     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.02.072     Document Type: Article

References (34)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 2 1988 349 360
2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682
3. G.W. Stone, C.L. Grines, and D. Rothbaum Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators J Am Coll Cardiol 29 1997 901 907
4. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock N Engl J Med 341 1999 625 634
5. R.V. Jeger, D. Radovanovic, and P.R. Hunziker Ten-year trends in the incidence and treatment of cardiogenic shock Ann Intern Med 149 2008 618 626
6. K.A. Fox, P.G. Steg, and K.A. Eagle Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
7. F.G. Kushner, M. Hand, and S.C. Smith Jr. Focused updates: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
8. K.A. Fox, P.A. Poole-Wilson, and R.A. Henderson Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina Lancet 360 2002 743 751
9. A.A. Bavry, D.J. Kumbhani, A.N. Rassi, D.L. Bhatt, and A.T. Askari Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials J Am Coll Cardiol 48 2006 1319 1325
10. J. Yamaguchi, H. Kasanuki, and Y. Ishii Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry) Am J Cardiol 93 2004 1526 1528
11. H. Kasanuki, T. Honda, and K. Haze A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI registry Am Heart J 150 2005 411 418
12. T. Shiga, N. Hagiwara, and H. Ogawa Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry Heart 95 2009 216 220
13. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513
14. S.P. de Boer, C.M. Westerhout, R.J. Simes, C.B. Granger, F. Zijlstra, and E. Boersma Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age JACC Cardiovasc Interv 3 2010 324 331
15. S.G. Coca, H.M. Krumholz, A.X. Garg, and C.R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease JAMA 296 2006 1377 1384
16. M.Y. Chan, J.L. Sun, and L.K. Newby Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction Circulation 119 2009 3110 3117
17. V.L. Roger, S.A. Weston, and Y. Gerber Trends in incidence, severity, and outcome of hospitalized myocardial infarction Circulation 121 2010 863 869
18. H. Ogawa, and S. Kojima Modern state of acute myocardial infarction in the interventional era: observational case-control study-Japanese acute coronary syndrome study (JACSS) J Cardiol 54 2009 1 9
19. H. Ogawa, M. Kawana, K. Tamura, S. Kimata, and S. Hosoda Long-term prognosis of medically treated patients with acute myocardial infarction and one-vessel coronary artery disease Am J Cardiol 73 1994 158 163
20. B. Dahlof Cardiovascular disease risk factors: epidemiology and risk assessment Am J Cardiol 105 2010 3A 9A
21. S. Yusuf Preventing vascular events due to elevated blood pressure Circulation 113 2006 2166 2168
22. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 2000 145 153
23. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
24. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
25. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
26. S. Colagiuri, and J. Best Lipid-lowering therapy in people with type 2 diabetes Curr Opin Lipidol 13 2002 617 623
27. A. Takara, H. Ogawa, and Y. Endoh Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization Cardiovasc Diabetol 9 2010 1 7
28. D.M. Nathan, J.B. Buse, and M.B. Davidson Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diab Care 32 2009 193 203
29. S. Kaul, A.F. Bolger, D. Herrington, R.P. Giugliano, and R.H. Eckel Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation Circulation 121 2010 1868 1877
30. D. Aguilar, B. Bozkurt, K. Ramasubbu, and A. Deswal Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes J Am Coll Cardiol 54 2009 422 428
31. D.J. Cohen, M. Doucet, D.E. Cutlip, K.K. Ho, J.J. Popma, and R.E. Kuntz Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation 104 2001 773 778
32. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
33. D.M. Henkel, M.M. Redfield, S.A. Weston, Y. Gerber, and V.L. Roger Death in heart failure: a community perspective Circ Heart Fail 1 2008 91 97
34. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2